Complications of transcatheter aortic valve implantation (TAVI): How to avoid and treat them

Heart

Volumn 101, Issue 11, 2015, Pages 900-908

  Möllmann, Helge ^a   Kim, Won Keun ^a   Kempfert, Jörg ^a   Walther, Thomas ^a   Hamm, Christian ^a,b  

^a KERCKHOFF HEART CENTER   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA ROOT; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; AORTIC ROOT RUPTURE; ARTICLE; BLOOD VESSEL OCCLUSION; BLOOD VESSEL RUPTURE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CORONARY ARTERY OBSTRUCTION; HEART TAMPONADE; HUMAN; KIDNEY FAILURE; PACEMAKER IMPLANTATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RISK FACTOR; TRANSCATHETER AORTIC VALVE IMPLANTATION; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; AORTIC RUPTURE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; ARTIFICIAL HEART PACEMAKER; CARDIAC TAMPONADE; CORONARY OCCLUSION; DEVICES; INTRAOPERATIVE COMPLICATIONS; OPERATIVE BLOOD LOSS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROSTHESIS IMPLANTATION; STATISTICS AND NUMERICAL DATA; STROKE;

ACUTE KIDNEY INJURY; AORTIC RUPTURE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BLOOD LOSS, SURGICAL; CARDIAC TAMPONADE; CORONARY OCCLUSION; HUMANS; INTRAOPERATIVE COMPLICATIONS; PACEMAKER, ARTIFICIAL; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RISK FACTORS; STROKE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84928406412     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304708     Document Type: Article

References (34)

1. Hamm CW, Mollmann H, Holzhey D, et al. The German Aortic Valve Registry (GARY): in-hospital outcome. Euro Heart J 2014;35:1588-98.
2. Important all-comers providing insights in contemporary real-world data.
3. Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint de finitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Euro Heart J 2012;33:2403-18.
4. Very important landmark manuscript on outcome and complications after TAVI.
5. Genereux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium defi nitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012;59:2317-26.
6. Sharma A, Arbab-Zadeh A, Dubey D, et al. Access site bleeding after transcatheter aortic valve implantation. J Thromb Thrombolysis 2013;35:463-8.
7. Ussia GP, Barbanti M, Petronio AS, et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Euro Heart J 2012;33:969-76.
8. Haulon S, Hassen Khodja R, Proudfoot CW, et al. A systematic literature review of the efficacy and safety of the Prostar XL device for the closure of large femoral arterial access sites in patients undergoing percutaneous endovascular aortic procedures. Euro J Vasc Endovasc Surg 2011;41:201-13.
9. Sharp AS, Michev I, Maisano F, et al. A new technique for vascular access management in transcatheter aortic valve implantation. Cath Cardiovasc Interv 2010;75:784-93.
10. Wendler O, Walther T, Schroefel H, et al. The SOURCE Registry: what is the learning curve in trans-apical aortic valve implantation? Euro J Cardiothoracic Surg 2011;39:853-9; discussion 9-60.
11. D'Onofrio A, Rubino P, Fusari M, et al. Clinical and hemodynamic outcomes of "all-comers" undergoing transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA). J Thoracic Cardiovasc Surg 2011;142:768-75.
12. Kempfert J, Rastan A, Holzhey D, et al. Transapical aortic valve implantation: analysis of risk factors and learning experience in 299 patients. Circ 2011;124:S124-9.
13. Blumenstein J, Kempfert J, Van Linden A, et al. First-in-man evaluation of the transapical APICA ASC access and closure device: the initial 10 patients. Euro J Cardiothoracic Surg 2013;44:1057-62; discussion 62.
14. Walther T, Mollmann H, van Linden A, et al. Transcatheter aortic valve implantation transapical: step by step. Sem Thoracic Cardiovasc Surg 2011;23:55-61.
15. Rezq A, Basavarajaiah S, Latib A, et al. Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation: a single-center study. JACC Cardiovasc Intervent 2012;5:1264-72.
16. Ribeiro HB, Nombela-Franco L, Urena M, et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic review. JACC Cardiovasc Intervent 2013;6:452-61.
17. Messika-Zeitoun D, Serfaty JM, Brochet E, et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010;55:186-94.
18. Mohr FW, Holzhey D, Mollmann H, et al. The German Aortic Valve Registry: 1-year results from 13 680 patients with aortic valve disease. Euro J Cardiothorac Surg 2014;46:808-16.
19. Weber M, Hausen M, Arnold R, et al. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation. Int J Cardiol 2008;127:321-7.
20. Van Linden A, Blumenstein J, Walther T, et al. Rescue valve-in-valve implantations in second generation transapical transcatheter aortic valve prostheses. Clin Res Cardiol 2013;102:241-3.
21. Mollmann H, Diemert P, Grube E, et al. Symetis ACURATE TF aortic bioprosthesis. EuroIntervention 2013;9(Suppl):S107-10.
22. Willson AB, Rodes-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J Am Coll Cardiol 2012;60:581-6.
23. Erkapic D, Kim WK, Weber M, et al. Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europacy 2010;12:1188-90.
24. Houthuizen P, van der Boon RM, Urena M, et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention 2014;9:1142-50.
25. Complete overview on conduction disturbances after TAVI.
26. Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation following transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circ 2014;129:1233-43.
27. Sinning JM, Ghanem A, Steinhauser H, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interven 2010;3:1141-9.
28. Stortecky S, Windecker S, Pilgrim T, et al. Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes. EuroIntervention 2012;8:62-70.
29. Complete overview on neurological events after TAVI.
30. Panchal HB, Ladia V, Desai S, et al. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events following transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol 2013;112:850-60.
31. Eggebrecht H, Schmermund A, Voigtlander T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012;8:129-38.
32. Comprehensive analysis on neurological outcomes after TAVI.
33. Praz F, Nietlispach F. Cerebral protection devices for transcatheter aortic valve implantation: is better the enemy of good? EuroIntervention 2013;9(Suppl):S124-8.
34. Nietlispach F. Cerebral protection devices for transcatheter aortic valve implantation. Cardiovascular Medicine 2012;15:287-92.